What severity of hypothyroidism (underactive thyroid) requires treatment during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hypothyroidism During Pregnancy

Both clinical (overt) hypothyroidism and subclinical hypothyroidism should be treated during pregnancy regardless of severity to prevent adverse maternal and fetal outcomes. 1

Definitions and Diagnostic Criteria

  • Overt hypothyroidism is characterized by elevated TSH with decreased free T4 levels 1
  • Subclinical hypothyroidism is identified by elevated TSH with normal free T4 levels in an asymptomatic pregnant woman 1
  • TSH testing using monoclonal antibodies is the recommended initial screening test for suspected thyroid disease in pregnancy 1

Risks of Untreated Hypothyroidism in Pregnancy

Maternal Risks:

  • Increased risk of preeclampsia 1
  • Higher rates of preterm delivery 1, 2
  • Pregnancy-induced hypertension (occurs in 22-44% of women with untreated hypothyroidism) 3
  • Placental abruption 1

Fetal/Neonatal Risks:

  • Low birth weight 1
  • Fetal death 1, 2
  • Congenital cretinism (with iodine deficiency) 1
  • Cognitive impairment in children (especially with first trimester hypothyroidism) 1, 3
  • Impaired neuropsychological development 1

Treatment Recommendations

  • All pregnant women with overt hypothyroidism require treatment 4
  • All pregnant women with subclinical hypothyroidism (regardless of TSH level) should be treated 4
  • Women planning pregnancy with hypothyroidism should be treated before conception with a target TSH of 1 mU/L 5
  • Levothyroxine is the treatment of choice for hypothyroidism during pregnancy 1, 3

Medication Management

  • Women already on thyroid replacement therapy often need dose increases by 4-6 weeks gestation 1
  • Dose increases typically range from 25-50% during the first trimester 5
  • Monitor thyroid function with TSH and free T4 or FTI every 2-4 weeks during pregnancy to guide dosage adjustments 6
  • The goal is to maintain TSH in the normal range and free T4 in the high-normal range 1, 5

Special Considerations

  • Women with positive thyroid antibodies (TPO-ab) have double the risk of miscarriage and may develop postpartum thyroiditis 3
  • Adequate treatment eliminates or significantly reduces the risks of complications 3, 2
  • After delivery, levothyroxine requirements typically decrease to pre-pregnancy levels 3

Monitoring Protocol

  • Screen high-risk women before or during early pregnancy (those with previous thyroid disease, type 1 diabetes, or family history of thyroid disorders) 3, 7
  • Perform TSH and free T4 testing in pregnant women with suspected hypothyroidism 1
  • Monitor TSH every trimester in treated women to ensure stable thyroid function 6

Key Pitfalls to Avoid

  • Delaying treatment of subclinical hypothyroidism in pregnancy (even mild cases should be treated) 1, 4
  • Inadequate dose adjustments during pregnancy (requirements often increase) 5, 3
  • Failure to monitor thyroid function regularly during pregnancy 6
  • Overlooking hypothyroidism in women with nonspecific symptoms that may be attributed to normal pregnancy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hypothyroidism during pregnancy.

Clinical obstetrics and gynecology, 1997

Research

[Pregnancy (conception) in hyper- or hypothyroidism].

Nederlands tijdschrift voor geneeskunde, 2001

Guideline

Management of Hyperthyroidism in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypothyroidism: A Review.

JAMA, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.